Admission Date:  [**2194-2-22**]              Discharge Date:   [**2194-3-2**]  Date of Birth:  [**2151-2-25**]             Sex:   M  Service: MEDICINE  Allergies: Ciprofloxacin / Metronidazole  Attending:[**First Name3 (LF) 1162**] Chief Complaint: abdominal pain  Major Surgical or Invasive Procedure: Diagnostic Cholangiogram [**2194-2-23**] EUS with pancreatic biopsy US guided liver biopsy   History of Present Illness: Mr. [**Known lastname 18252**] is a 42 yo man with no significant PMH who initially presented [**2-12**] with ~6 weeks of decreased appetite, 10-pound weight loss and about a week of painless jaundice.
They were unable to cannulate the CBD, and a percutaneous cholecystostomy tube was placed by interventional radiology.
He was discharged on a 10-day course of ciprofloxacin and metronidazole, but developed a rash after only 3 days.
In spite of that, he continued the antibiotics for nearly their entire course.
He was given 1L NS, ampicillin-sulbactam, antiemetics and hydromorphone and transferred to the [**Hospital Unit Name 153**] for further management.
1 drink of ETOH/day   Family History: no family history of medical problems  Physical Exam: Vitals: T: 96.7 BP: 134/70 P: 77 R: 10 SaO2: 94% on RA General: Vomiting during exam, awake, alert, oriented X3, cooperative HEENT: NCAT, PERRL 3->2, EOMI, + scleral icterus, MM dry Neck: no significant JVD Pulmonary: Lungs CTA bilaterally, no wheezes, ronchi or rales Cardiac: RR, nl S1 S2, no murmurs, rubs or gallops appreciated Abdomen: tender throughout, most significantly in RLQ, + guarding, mild rebound tenderness, hypoactive bowel sounds Extremities: No edema, 2+ radial, DP pulses b/l Skin: diffuse macular erythematous rash   Pertinent Results: [**2194-2-22**] 10:21PM   PT-14.1* PTT-30.4 INR(PT)-1.2* [**2194-2-22**] 05:50PM   GLUCOSE-137* UREA N-11 CREAT-0.8 SODIUM-132* POTASSIUM-4.2 CHLORIDE-92* TOTAL CO2-27 ANION GAP-17 [**2194-2-22**] 05:50PM   ALT(SGPT)-98* AST(SGOT)-36 ALK PHOS-572* AMYLASE-26 TOT BILI-5.0* [**2194-2-22**] 05:50PM   LIPASE-37 [**2194-2-22**] 05:50PM   WBC-20.1*# RBC-4.53* HGB-13.5* HCT-38.9* MCV-86 MCH-29.8 MCHC-34.8 RDW-14.6 [**2194-2-22**] 05:50PM   NEUTS-92.1* LYMPHS-2.7* MONOS-4.6 EOS-0.3 BASOS-0.2 [**2194-2-22**] 05:50PM   PLT COUNT-403 [**2194-2-22**] 05:49PM   LACTATE-1.3  Blood Culture, Routine (Final [**2194-3-1**]):       STAPHYLOCOCCUS, COAGULASE NEGATIVE.
ISOLATED FROM ONE SET ONLY SENSITIVITIES PERFORMED ON REQUEST..     Aerobic Bottle Gram Stain (Final [**2194-2-24**]):       REPORTED BY PHONE TO [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **] AT 2120 ON [**2-24**]..       GRAM POSITIVE COCCI IN PAIRS AND CLUSTERS.
There has been interval placement of a percutaneous transhepatic biliary catheter with pigtail termination in the duodenum, in good position.
A right inguinal hernia is noted with pelvic fluid extending into the processus vaginalis.
Abdominal pain, fever: The patient's initial presentation was concerning for ascending cholangitis, although his perc drain was in place and extending through the duodenum.
External biliary drain was uncapped by interventional radiology on [**2-23**] and left draining externally.
The proximal sideport of the drain was withdrawn for better drainage of intrahepatic ducts and the patients LFTs and obstructive picture improved over the course of the hospitalization.
There was significant leukocytosis on admission and given his prior reaction to cipro and flagyl the patient was initially managed on IV Unasyn.
This was transitioned to Augmentin with good tolerance.
He was pan-cultured and a PICC line was placed for transition to Zosyn for a 10 day course to be completed as an outpatient.
He was adequately managed on MS Contin with oxycodone for breakthrough.
Tylenol was avoided during his stay given his hepatic involvement and NSAIDs were minimized secondary to frequent planned interventions.
A bowel regimen was given while on narcotics.
Pancreatic head mass: The EUS FNA biopsy was consistent with carcinoma with neuroendocrine features.
Medications on Admission: Oxycodone 5 mg 1-3 Tablets PO q3h prn  Discharge Medications: 1.
Senna 8.6 mg Tablet Sig: 1-2 Tablets PO BID (2 times a day).
Oxycodone 5 mg Tablet Sig: Two (2) Tablet PO Q4H (every 4 hours) as needed.
Morphine 30 mg Tablet Sustained Release Sig: One (1) Tablet Sustained Release PO Q12H (every 12 hours).
Pantoprazole 40 mg Tablet, Delayed Release (E.C.)
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Bisacodyl 5 mg Tablet, Delayed Release (E.C.)
9. heparin 10 ml of normal saline followed by 2 ml of 100u/ml of heparin.
200u heparin in PICC daily.
Discharge Disposition: Home With Service  Facility: Critical Care Systems  Discharge Diagnosis: ascending cholangitis pancreatic tumor   Discharge Condition: stable, tolerating po, afebrile   Discharge Instructions: You were admitted with abdominal pain and were treated for ascending cholangitis.
